相关实验视频
Updated: Jan 14, 2026

08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
7.5K
皮肤表现和皮肤不良事件在IBD:临床更新
Dimitrios Tsilimpotis1, Georgia Kyriakou1, Luc Biedermann2
1Department of Dermatology, Medical School, University of Patras, 26504 Patras, Greece.
Inflammatory bowel diseases
|October 24, 2025
概括
炎症性肠道疾病 (IBD) 与许多皮肤疾病有关,影响患者的生活质量. 了解肠-皮肤轴和生物治疗效果对于有效的IBD和皮肤病治疗至关重要.
科学领域:
- 胃肠病学 胃肠病学
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
背景情况:
- 炎症性肠道疾病 (IBD),如克罗恩氏病和性结肠炎,涉及慢性炎症和肠外表现.
- 皮肤病是IBD常见的并发症,显著影响患者的生活质量 (QoL).
研究的目的:
- 审查IBD和皮肤表现之间的复杂关系.
- 讨论生物疗法对IBD患者皮肤状况的影响.
- 突出肠-皮肤轴及其在IBD相关皮肤病中的作用.
主要方法:
- 综合文献综述,重点关注IBD和皮肤病症状.
- 对特定疾病的分析:红斑结节,皮肤质,甜蜜综合征,性腺炎,牛皮和白.
- 检查生物疗法,其副作用和矛盾的皮肤反应.
主要成果:
- IBD与各种皮肤疾病有关,包括自身免疫和炎症性皮肤病.
- 生物疗法可以引起有益和有害的皮肤学影响,包括独特的皮疹.
- 肠-皮肤轴展示了共同的途径,影响了胃肠道和皮肤健康.
结论:
- 跨学科的护理对于管理IBD相关的皮肤问题至关重要.
- 了解肠-皮肤轴可以为皮肤并发症的IBD患者提供量身定制的治疗方法.
- 这一综述为临床医生提供了优化患者治疗结果的实用见解.
关键词:
克罗恩病是什么 克罗恩病IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD生物学的生物学.皮肤学表现 皮肤学表现肠外肠道 肠外肠道性结肠炎是一种更多相关视频
相关概念视频
Inflammatory Bowel Disease II: Crohn's Disease
947
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
947
Inflammatory Bowel Disease I: Ulcerative Colitis
891
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
891
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
635
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
635
Chronic Bowel Disorders: Introduction
744
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
744
Inflammatory Bowel Disease IV: Pharmacological Management
496
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
496
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
483
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
483

